Medyria raises $3.9M (Switzerland, Jul 2026)

$3.9M
CHF 3.5 million

Find the investors funding Health rounds

326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.

Find your investors →
Generated social card
Medyria social card
Headline

Medyria raises CHF 3.5 million - Startupticker.ch

About

Medyria is a Swiss medical technology pioneer specializing in invasive coronary diagnostics. The company develops blood-flow-velocity sensors and catheter technologies, with its lead product, PyCath, designed to measure blood flow velocity during interventional cardiology procedures.

Article summary

Medyria raises CHF 3.5 million  Startupticker.ch

Founder
Mauro M. Sette
Mauro M. Sette
CEO
Investors
Related rounds
Oct 27, 2026Atlas Bio$12.5M—Switzerland
Oct 22, 2026Enact$30.0MPre-seedSwitzerland
Oct 19, 2026Nouscom$120.0M—Switzerland
Oct 09, 2026Klarent$7.7MSeedSwitzerland

12,002 investors back startups in Switzerland

You just read who funded Medyria. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 15 investor contact unlocks a month, no card required.

About the investors in Switzerland